Want to join the conversation?
$EL 4Q15 Q&A: Wissink from Piper Jaffray asked about the guidance. Tracy said, growth levers that we have in FY16 are much like they were in FY15. We saw tremendous strength in makeup category. Certainly over next three years, we expect one-third split between margin expansion & gross profit marginl; & two-third is coming from expense leverage.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?